![]() Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. | Zyngenia Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways. | |||
Founding Date | Founding Date 2010 | Founding Date 2009 | Founding Date 1992 | Founding Date 2009 |
Type | Type Subsidiary | Type Private | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US | Locations Washington, US HQ | Locations Somerville, US HQ | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more |
Employees | Employees 43 | Employees N/A | Employees 32338% decrease | Employees 4,008 |
Financial | ||||
Revenue (est.) | Revenue (est.) $8.3m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $83.8m (FY, 2024) | Revenue (est.) N/A |
Net income | Net income ($108.9m) (FY, 2020) | Net income N/A | Net income ($240.7m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 21.3m | Total funding raised $ 25m | Total funding raised $ 409m | Total funding raised $ 85.3m |
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
View companyBluebird Bio is a developer of gene therapies for severe genetic diseases.
View companyKite Pharma is a company developing cancer immunotherapy products based on cell therapy.
View company